Abstract
INTRODUCTION
By 2030 it is projected that 7.7% of the world's popu lation will have diabetes, which is an increase of 54% since 2010 [1] . Individuals with type 1 and type 2 dia betes are twotothree times more likely to develop cardiovascular disease (CVD) compared with the general population [24] . In Australia, in 2010 approximately 30% of all deaths in people with type 1 and type 2 diabetes were due to CVD [5] . Poor diet is the leading contributor to the global burden of disease [6] and better dietary quality is associated with lower rates of CVD [7, 8] . The most recent evidence from prospective cohort studies suggests that dairy consumption is protective against CVD [9] . Although uncertainty remains about the vascular effects of dairy fatty acids [10] . Arterial stiffness measured by augmentation index and carotid femoral pulse wave velocity (cfPWV) are independent predictors of CVD [11, 12] . Similarly, carotid intima media thickness (IMT) is an early measure of atherosclerosis that predicts CVD [13, 14] . Epidemiological studies have indicated that higher consumption of dairy products is associated with lower carotid IMT [15, 16] and less arterial stiffening [15, 1719] . Selfreported dietary intake is limited by inaccurate reporting, which is welldocumented in the general popu lation and people with diabetes [20] . Biomarkers of dietary intake, including dairy consumption, remove the reliance on selfreported dietary data. Previously it has been shown that fatty acids of ruminant origin are correlated with self reported dietary intake of dairy products [19, 21] . The aim is to determine serum lipid species that change in response to a change in dairy consumption. Based on our previous analysis [19] we hypothesise that the following lipid species will reflect a change in dairy consumption: Cholesterol ester (CE) The secondary aims are to determine the correlation between the change in dairy associated lipid species and 3mo change in peripheral and central blood pressure, augmentation index and cfPWV. The 12mo change in common carotid artery intima media thickness (CCAIMT) will also be correlated with the change in lipid species.
MATERIALS AND METHODS

Study design
As previously reported, a 12mo randomised controlled trial was conducted to determine the effect of improving dietary quality on CCAIMT, compared to a control group continuing on their habitual diet, in a cohort of people with type 1 and type 2 diabetes [22] . Briefly, participants were randomised to increase consumption of fruit (+1 serve/day), vegetables (+2 serves/day) and dairy (+1 serve/day), regardless of usual intake or to continue on their usual diet. One serve of dairy was either 250 mL of milk or 200 g of yoghurt and no advice was given regarding the fat content. Dietary counselling was provided by a dietitian. Ethics approval was obtained from the University of South Australian Human Research Ethics Committee and the participants provided written informed consent. The trial was registered with the Australian New Zealand Clinical Trials Registry (ACTRN12613000251729) on 04/09/2014.
A post hoc analysis was conducted that comprised a subsample of the cohort (n = 108) that had serum lipidomic analysis performed at baseline and 3mo. A food frequency questionnaire (FFQ) was used to measure dietary intake at baseline and 3mo and a fasting serum sample was collected for measurement of lipid species. Participants had peripheral and central blood pressure, augmentation index and cfPWV measured at baseline and 3mo. In addition, CCAIMT was measured at baseline and 12mo. The intervention to increase dairy by one serve per day was only partially successful with 34 people in the intervention group increasing and 17 decreasing their dairy consumption, while in the control group 23 increased and 34 reduced their dairy intake. Thus overall 57 people increased and 51 decreased dairy intake so the analyses were performed without regard for allocation to intervention or control.
Subjects
Subjects above 18 years of age with diagnosed type 1 or type 2 diabetes for any duration managed with diet, oral hypoglycaemic agents (OHA) and/or insulin were recruited from August 2012 until December 2013 from a database of volunteers, public advertisements and a recruitment company (Intuito Market Research, Adelaide, South Australia). Exclusion criteria were: Unstable CVD requiring active intervention, heart failure, significant renal impairment (eGFR < 30 mL/min), liver disease, cancer or allergic/intolerant/dislike of fruit, vegetables or dairy.
Serum lipid analysis
Lipid analysis was performed on fasting serum by liquid chromatography, electrospray ionizationtandem mass spectrometry as previously published [23] . In total, 342 individual lipid species were measured from 23 classes.
Food frequency questionnaire
Habitual dietary intake was measured using the elec tronic version of the Dietary Questionnaire for Epi demiological Studies Version 2 FFQ. The FFQ includes questions on the types of milk (fat content), cheese (hard, firm, soft, ricotta, cottage cheese, cream cheese or low fat cheese) and spreads (butter) used. Questions about the quantity of milk consumed per day (none, < 250 mL, 250500 mL, 500750 mL, > 750 mL) and the frequency of cheese, yoghurt and icecream consumption are also included. This FFQ has been found to have relatively good agreement with a 3d weighed food record in the general population [24] and in people with type 1 and type 2 diabetes [25] .
Measurements
Anthropometric measurements: Height was measured using a stadiometer (SECA, Hamburg, Germany) to the nearest 0.1 cm while barefoot/flat footwear. Weight was measured to the nearest 0.05 kg using calibrated electronic scales (SECA, Hamburg, Germany) while the participants were barefoot/light footwear and wore light clothing.
Peripheral blood pressure: Clinic blood pressure was measured using an automated sphygmomanometer (SureSigns VS3; Philips, North Ryde, Sydney, Australia) once the participant had been seated for 5 min. A normal sleeve (16 cm × 52 cm) was used for an arm circumference of 2432 cm and a large sleeve (16 cm × 70 cm) for an arm circumference of 3242 cm. A minimum of four consecutive readings were taken at 1 min intervals. The first reading was discarded and the following three consistent measurements, i.e., systolic blood pressure within a range of 1.3 kPa, were used.
Common carotid artery intima media thickness:
The measurements of the carotid artery were taken using B mode ultrasound by one operator, with an intra observer coefficient of variation (CV) of 4.4% (n = 34). The participants were supine with their head positioned at 45 degrees away from the side of the neck being measured. A high resolution ultrasound machine with a 12 MHz transducer was used (Samsung Medison MySono U6, South Korea). A 1 cm region of the IMT on the far wall of the distal common carotid artery on both sides was measured using automatic edge detection software (Samsung Medison MySono U6 Auto IMT, South Korea) as recommended in the Mannheim Carotid Intima Media Thickness Consensus Paper (200420062011) [26] . Areas of plaque, defined as a 50% greater IMT than the surrounding IMT or IMT > 1.5 mm, were not imaged. Three seconds clips were captured and the mean of 10 measurements taken from each of these clips was averaged for a mean and mean maximum CCAIMT value at baseline and 12 mo.
Central blood pressure and augmentation
Ryde, Sydney, Australia) was used to measure central blood pressure and augmentation index. A cuff was placed over the brachial artery on the right arm and measurements were completed after the participants had been quietly resting for 5 min. Three consecutive measurements were taken and the average calculated. All of the measurements were taken by one operator with a CV of 4.2% (n = 28).
Pulse wave velocity:
A SphygmoCor ® XCEL (AtCor Medical, West Ryde, Sydney, Australia) was used to measure cfPWV. The tonometer was placed on the right carotid artery and the cuff on the right femoral artery. A 10s recording of the carotidfemoral waveform was taken. Three measurements were performed at each timepoint and an average taken. The measurements were taken by two operators; the intraobserver CVs were 4.2% (n = 28) and 7.3% (n = 11), respectively and the interobserver CV was 5.0% (n = 18).
Statistical analysis
Data are presented as mean ± SD. The change in dairy intake between baseline and 3mo was not different between the groups so the cohort was analysed as a whole. Paired samples ttests were used to determine the change in dairy intake, anthropometric measures, blood pressure, biochemistry and vascular measurements over time. Secondary analyses involving all of the lipid species (> 300) were conducted. Spearman's correlation was used to determine the association between the change in lipid species and the change in vascular measures. In addition, baseline concentrations of the lipid species were correlated with the change in vascular measures. These secondary analyses were corrected for multiple comparisons using the Benjamini Hochberg approach [30] . Analyses were performed using SPSS (version 19, 2010, SPSS Inc, Chicago, IL, United States). Statistical significance was set at p < 0.05. The statistical methods of this study were reviewed by Ms Kylie Lange from the University of Adelaide, Australia.
RESULTS
A total of 108 participants were involved in these an alyses (Figure 1 ). Baseline characteristics of the parti cipants included in this subsample were not different from nonparticipants with regards to age, weight, BMI, peripheral blood pressure, central systolic blood pressure, mean or mean maximum CCAIMT. Central diastolic blood pressure, augmentation index, cfPWV and HbA1c were higher (p < 0.05) in the nonparticipants compared with the participants. Baseline characteristics of the participants are presented in Table 1 . Table 2 shows consumption of dairy products mea sured using the FFQ. There was no significant change in total or full fat dairy consumption over time. Yoghurt consumption increased while cheese and butter consump tion decreased. There was no effect of the treatment on dairy consumption or lipid levels, so we were able to examine the association between the change in dairy intake and the change in lipid species in the entire cohort to identify dairy associated lipid species. And we further analysed the correlation between the change in dairy associated lipid species and vascular measurements. Table 3 shows the results of correlating the change in lipid species containing 15:0, 16:1 or 17:0 or those identified as correlating with dairy intake in the previous crosssectional study with the change in full fat dairy consumption (milk, yoghurt, cheese, butter and ice cream). No adjustments were made. Table 4 shows the anthropometric measurements, blood pressure, biochemistry and vascular measurements at baseline and followup in the whole group. Measurements of central blood pressure and augmentation index were performed on 82 participants due to equipment availa bility. cfPWV was performed on 70 participants due to technical difficulties because of obesity. The lipid species that were shown to be correlated with total full fat dairy consumption (LPC 14:0, LPC 15:0, LPC 16:1, PC 29:0, PC 30:0, PC 31:0, CE 14:0) were then correlated with the vascular measurements that changed over time. Table 5 Fatty acids C 15:0 and C 17:0 are not produced endogenously and are constituents of dairy fat. The fatty acid C 14:0 is produced endogenously but is also a component of dairy fat. Therefore these fatty acids in plasma or for C 14:0 in adipose tissue are considered biomarkers of dairy intake [28] . In the present study change in LPC 15:0, LPC 14:0 and CE 14:0 were weakly positively correlated with the change in consumption of full fat dairy. LPC concentration in milk fat is < 1% of the total PC concentration and therefore dairy would be an unlikely direct source of LPC species [21] . LPC lipid species are predominately produced endogenously through a number of different processes including from PC by phospholipase A2 enzyme and the oxidation of LDL particles [31, 32] . In a randomised crossover study, consumption of a full fat dairy diet containing nonfermented products (butter, cream or ice cream) was associated with higher plasma concentrations of sphingomyelin compared with lowfat dairy intake [33] . Plasma concentrations of odd chain phosphatidylcholine (15:0 and 17:0) were increased with consumption of both full fat fermented (including yoghurt and cheese) and nonfermented dairy products. In this study vascular measurements were not performed. Previously we showed a crosssectional association between serum lipid species and consumption of full fat dairy in people with type 1 and type 2 diabetes but serum lipid species were not associated with arterial stiffness despite dairy consumption being inversely associated with cfPWV [19] . In addition, baseline CCA IMT was not associated with any serum lipid species. In the present study, changes in serum lipid species were associated with the change in central blood pressure (LPC 14:0, LPC 15:0, LPC 16:1, PC 29:0, PC 30:0, PC 31:0) and the change in CCAIMT (CE 14:0). In addition, baseline concentration of PC 34:4, PC 32:2, GM3 16:0, GM3 18:0 and total GM3 were associated with the change in CCAIMT such that higher baseline levels were associated with greater CCAIMT regression. GM3 accumulation has been observed in intimal atherosclerotic lesions in the carotid artery and aorta [34] and serum GM3 has been identified as a potential marker of early atherosclerosis [35] . Therefore this finding suggests that those with greater atherosclerotic burden at baseline had greater CCAIMT regression which is consistent with our previous finding [22] . This study shows that when dairy associated serum lipids species were reduced at 3mo there was a reduction in central blood pressure and CCAIMT. Conversely when there was an increase in these serum lipid species central blood pressure increased. This finding is not consistent with previous research showing an inverse association between dairy consumption and blood pressure [17, 36] . Machin et al [36] showed that consuming a high dairy diet (nonfat) for 4 wk reduced central blood pressure and cfPWV compared with a high fruit diet. The relationship we observed whereby an increase in LPC 14:0, LPC 15:0 and LPC 16:1 was associated with an increase in central blood pressure may be explained by the proinflammatory and atherogenic properties of nonomega 3 polyunsaturated fatty acid enriched LPC [37] . LPCs act on endothelial cells, smooth muscle cells, monocytes, macrophages and Tcells in a number of ways to inhibit endothelial relaxation and upregulate production of inflammatory and adhesion molecules [32, 38] . Inflammation, measured by CRP, has been positively associated with blood pressure and development of hypertension [39, 40] , which may explain our findings in the current study. As such, our results may not be due to the fatty acid composition per se but fatty acid metabolism and resulting lipid species. Previously total phospholipid C 15:0 has been inversely associated with blood pressure and coronary heart disease [41] . Although it remains unclear what the mechanism behind this finding is and this should be explored in the future.
Ruminant fatty acids C 15:0 and C 17:0 do not have the same physiological effects as other saturated fatty acids (although they have not been tested in isolation) and are not associated with increased risk of cardiovascular outcomes and may actually be protective [42, 43] . Dairy products also contain many other components such calcium, magnesium, phosphorus, potassium and bioactive peptides that may contribute to the cardioprotective effect of dairy consumption [4446] . In a fourway crossover study it was shown that the calcium content of dairy products counteracts the fat content to attenuate the increase in total and LDL cholesterol, without reducing HDL cholesterol [44] . The synergist effect of the different components in dairy products may explain why dairy consumption was not associated with any of the vascular measurements in the current study despite the observed association between the lipid species and these measurements.
Nestel et al [21] showed that the phospholipid classes LPC and lysoalkylphosphatidylcholine were associated with measures of insulin sensitivity and insulin resistance. In addition, full fat dairy consumption was associated with phospholipid fatty acids C 15:0, C 16:1 and C 18:1 n7 but there was no relationship detected between dairy consumption and insulin sensitivity or resistance measures. This is similar to the findings of the present study whereby the change in dairy consumption was not associated with the change in central blood pressure or CCAIMT, but the change in a number of lipid species was associated with both the change in dairy intake and the change in central blood pressure and CCAIMT. This may be because lipid analysis provides a more objective measure of intake and is not limited by the measurement error associated with selfreported dietary intake, although it may be due to a lack of statistical power. Limitations of this study are that it is observational and therefore causation cannot be established. In addition, just over half of the cohort were prescribed lipid lowering medication which may confound the results. Finally, this study comprises a small sample size and findings should be replicated in a larger cohort. We also did not have lipidomic data at 12mo but we assumed changes early in the observation period would be required in order see changes in IMT at 12mo.
In conclusion, in this cohort with type 1 and type 2 diabetes a number of serum lipid species that were associated with a change in full fat dairy consumption were also correlated with the 3mo change in central blood pressure and 12mo change in CCAIMT.
ACKNOWLEDGMENTS
The authors of this study would like to acknowledge the contributions of study participants and the staff of the University of South Australia. We would like to thank Dr. Eva Pedersen for her help with data collection and providing nutritional counselling.
COMMENTS
Background
People with diabetes are at higher risk of cardiovascular disease than the general population. And poor diet is a leading contributor to the development of cardiovascular disease. At present the effect of dairy consumption on vascular health is unclear. In this study the authors aimed to determine lipid species that change in response to a change in dairy consumption. In addition, to investigate whether dairy associated lipid species are correlated with changes in measures of vascular structure and function.
Research frontiers
Measurement of dietary intake is challenging due to inaccurate reporting, which is well documented in people with diabetes. Previously it has been shown that serum lipid species of ruminant origin are correlated with dairy consumption. In this study, the authors investigated the association between dairy intake measured by dietary questionnaire and serum lipid species and vascular health.
Innovations and breakthroughs
These analyses show that a change in the concentration of a number of serum lipid species (LPC 14:0, LPC 15:0, LPC 16:1, PC 29:0 PC 30:0, PC 31:0, CE 14:0), previously shown to be correlated with dairy consumption, were associated with a change in full fat dairy consumption. One or more of these lipid species were positively associated with the 3-mo change in central blood pressure and 12-mo change in common carotid artery intima media thickness (CCA-IMT) in this cohort with type 1 and type 2 diabetes.
Applications
Due to the observational nature of this research these findings are hypothesis generating and should be confirmed in the future.
Terminology
CCA-IMT is visualized using B mode ultrasound. The intima-media complex is the area of tissue starting at the luminal edge of the artery and ending at the boundary between the media and the adventitia. CCA-IMT is a measure of early atherosclerosis. Augmentation index and carotid femoral pulse wave velocity are non-invasive measures of arterial stiffness.
Peer-review
In the manuscript, the authors conducted a subanalysis of a previous randomized trial addressing the role of diary intake on vascular function and blood pressure parameters. They documented a significant relationship between blood pressure and augmentation index and certain lipid parameters. The study is well conducted with a huge number of parameters analysed and the results are intriguing.
